Your browser doesn't support javascript.
loading
First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.
Bernard Stoecklin, Sibylle; Rolland, Patrick; Silue, Yassoungo; Mailles, Alexandra; Campese, Christine; Simondon, Anne; Mechain, Matthieu; Meurice, Laure; Nguyen, Mathieu; Bassi, Clément; Yamani, Estelle; Behillil, Sylvie; Ismael, Sophie; Nguyen, Duc; Malvy, Denis; Lescure, François Xavier; Georges, Scarlett; Lazarus, Clément; Tabaï, Anouk; Stempfelet, Morgane; Enouf, Vincent; Coignard, Bruno; Levy-Bruhl, Daniel.
Afiliação
  • Bernard Stoecklin S; Santé publique France, Direction des maladies infectieuses, Saint-Maurice, France.
  • Rolland P; Santé publique France, Direction des régions, Saint-Maurice, France.
  • Silue Y; Santé publique France, Direction des régions, Cellule Régionale Ile-de-France, Paris, France.
  • Mailles A; Santé publique France, Direction des maladies infectieuses, Saint-Maurice, France.
  • Campese C; Santé publique France, Direction des maladies infectieuses, Saint-Maurice, France.
  • Simondon A; Agence Régionale de Santé Ile-de-France, Paris, France.
  • Mechain M; Agence Régionale de Santé Nouvelle-Aquitaine, Bordeaux, France.
  • Meurice L; Santé publique France, Direction des régions, Cellule Régionale Nouvelle-Aquitaine, Bordeaux, France.
  • Nguyen M; Agence Régionale de Santé Nouvelle-Aquitaine, Bordeaux, France.
  • Bassi C; Santé publique France, Direction des régions, Cellule Régionale Ile-de-France, Paris, France.
  • Yamani E; Agence Régionale de Santé Ile-de-France, Paris, France.
  • Behillil S; Centre National de Référence des virus des infections respiratoires, dont la grippe, Institut Pasteur, Paris, France.
  • Ismael S; AP-HP, Hôpital Bichat, Service des maladies infectieuses et tropicales, Paris, France.
  • Nguyen D; Centre Hospitalier Universitaire de Bordeaux, Service des maladies infectieuses et tropicales, Bordeaux GeoSentinel Site, Bordeaux, France.
  • Malvy D; UMR 1219, Université de Bordeaux, Bordeaux, France.
  • Lescure FX; Centre Hospitalier Universitaire de Bordeaux, Service des maladies infectieuses et tropicales, Bordeaux GeoSentinel Site, Bordeaux, France.
  • Georges S; Université de Paris, IAME, INSERM, Paris, France.
  • Lazarus C; AP-HP, Hôpital Bichat, Service des maladies infectieuses et tropicales, Paris, France.
  • Tabaï A; Santé publique France, Direction des maladies infectieuses, Saint-Maurice, France.
  • Stempfelet M; Direction Générale de la Santé, Ministère des solidarités et de la santé, Centre opérationnel de réception et de régulation des urgences sanitaires et sociales, Paris, France.
  • Enouf V; Santé publique France, Direction alerte et crise, Saint-Maurice, France.
  • Coignard B; Santé publique France, Direction alerte et crise, Saint-Maurice, France.
  • Levy-Bruhl D; Centre National de Référence des virus des infections respiratoires, dont la grippe, Institut Pasteur, Paris, France.
Euro Surveill ; 25(6)2020 02.
Article em En | MEDLINE | ID: mdl-32070465
A novel coronavirus (severe acute respiratory syndrome coronavirus 2, SARS-CoV-2) causing a cluster of respiratory infections (coronavirus disease 2019, COVID-19) in Wuhan, China, was identified on 7 January 2020. The epidemic quickly disseminated from Wuhan and as at 12 February 2020, 45,179 cases have been confirmed in 25 countries, including 1,116 deaths. Strengthened surveillance was implemented in France on 10 January 2020 in order to identify imported cases early and prevent secondary transmission. Three categories of risk exposure and follow-up procedure were defined for contacts. Three cases of COVID-19 were confirmed on 24 January, the first cases in Europe. Contact tracing was immediately initiated. Five contacts were evaluated as at low risk of exposure and 18 at moderate/high risk. As at 12 February 2020, two cases have been discharged and the third one remains symptomatic with a persistent cough, and no secondary transmission has been identified. Effective collaboration between all parties involved in the surveillance and response to emerging threats is required to detect imported cases early and to implement adequate control measures.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Vigilância da População / Busca de Comunicante / Controle de Infecções / Infecções por Coronavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Limite: Adult / Humans / Male / Middle aged País/Região como assunto: Asia / Europa Idioma: En Revista: Euro Surveill Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Vigilância da População / Busca de Comunicante / Controle de Infecções / Infecções por Coronavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Aspecto: Patient_preference Limite: Adult / Humans / Male / Middle aged País/Região como assunto: Asia / Europa Idioma: En Revista: Euro Surveill Ano de publicação: 2020 Tipo de documento: Article